Austin V. Arnett

  • 330 North Wabash Avenue, Suite 2800
  • Chicago, IL 60611
  • USA
Profile Experience

Austin Arnett is a member of the firm’s Corporate Department. Mr. Arnett works with companies, underwriters, and investors to execute successful capital markets transactions, and advises private and public companies on a variety of corporate and securities law matters.

Mr. Arnett also maintains an active pro bono practice. Prior to joining the firm, he served as a Fellow at the Loyola University Business Law Clinic, where he advised entrepreneurs and nonprofit organizations on a variety of organizational, corporate governance, and tax matters. At the firm, he continues to advise several nonprofit organizations on these and other legal matters.

While attending the University of Michigan Law School, Mr. Arnett served as an associate editor of the Michigan Law Review.

Mr. Arnett has recently advised:

Capital Markets

  • Levi Strauss & Co.*, Harpoon Therapeutics, Inc.*, and OrthoPediatrics Corp. in their initial public offerings
  • Aon plc, DocuSign, Inc.*, Ventas Inc., ShotSpotter, Inc.*, and Entercom Communications Corp. in registered debt and/or equity offerings
  • The underwriters in the initial public offerings of Bluegreen Vacations Corporation, Construction Partners, Inc., Duluth Holdings Inc. (d/b/a Duluth Trading Co.), and TransUnion
  • The underwriters in registered equity offerings for Assembly Biosciences, Inc., John Bean Technologies Corporation, TransUnion, and WageWorks, Inc.
  • The initial purchasers in high-yield debt offerings for Clearwater Seafoods Incorporated and Waste Pro USA, Inc.
Mergers and Acquisitions
  • Aon plc in its pending combination with Willis Towers Watson PLC
  • GTCR LLC in its acquisition of Onvoy, LLC, and Onvoy’s subsequent acquisitions of ANZ Communications, LLC and Inteliquent, Inc.
  • Delphi Automotive Systems plc in the sale of its global thermal systems business to MAHLE GmbH
Company Representation
  • Aon plc in its redomiciliation from the United Kingdom to Ireland
  • Inc., Harpoon Therapeutics, Inc.*, and Levi Strauss & Co.* in connection with a variety of legal matters, including corporate governance, securities law compliance, commercial transactions, and shareholder activism

*Matter handled prior to joining Latham

Notice: We appreciate your interest in Latham & Watkins. If your inquiry relates to a legal matter and you are not already a current client of the firm, please do not transmit any confidential information to us. Before taking on a representation, we must determine whether we are in a position to assist you and agree on the terms and conditions of engagement with you. Until we have completed such steps, we will not be deemed to have a lawyer-client relationship with you, and will have no duty to keep confidential the information we receive from you. Thank you for your understanding.